Olfactomedin‐4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers

Publisher: John Wiley & Sons Inc

E-ISSN: 1862-8354|9|1-2|58-63

ISSN: 1862-8346

Source: PROTEOMICS - CLINICAL APPLICATIONS, Vol.9, Iss.1-2, 2015-02, pp. : 58-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract